Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway-Reference-Cited by-同舟云学术

Combination therapy with miR34a and doxorubicin synergistically inhibits Dox-resistant breast cancer progression via down-regulation of Snail through suppressing Notch/NF-κB and RAS/RAF/MEK/ERK signaling pathway

Published:2021-09 Issue:9 Volume:11 Page:2819-2834
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Yang Xiaoxia,Shang Pengfei,Yu Bingfang,Jin Qiuyang,Liao Jing,Wang Lei,Ji Jianbo,Guo Xiuli

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference56 articles.

1. Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer;Coley;Cancer Treat Rev,2008

2. Targeting slug-mediated non-canonical activation of c-Met to overcome chemo-resistance in metastatic ovarian cancer cells;Chang;Acta Pharm Sin B,2019

3. Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer;Zheng;Biomed Pharmacother,2018

4. Natural products as multidrug resistance modulators in cancer;Kumar;Eur J Med Chem,2019

5. Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer;Liang;J Nanobiotechnol,2020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homologous Tumor Cell-Derived Biomimetic Nano-Trojan Horse Integrating Chemotherapy with Genetherapy for Boosting Triple-Negative Breast Cancer Therapy;ACS Applied Materials & Interfaces;2024-08-14

2. Ribonucleotide reductase small subunit M2 promotes the proliferation of esophageal squamous cell carcinoma cells via HuR-mediated mRNA stabilization;Acta Pharmaceutica Sinica B;2024-08

3. Versatile function of NF-ĸB in inflammation and cancer;Experimental Hematology & Oncology;2024-07-16

4. NF-κB signaling in therapy resistance of breast cancer: Mechanisms, approaches, and challenges;Life Sciences;2024-07

5. 4-Deoxy-ε-Pyrromycinone: A Promising Drug/Lead Compound to Treat Tumors;Drug Design, Development and Therapy;2024-06